Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0216352 REDOX SIGNALING GEL FORMULATION
Redox signaling gels are disclosed. Such gels include a composition with at least one reactive oxygen species (ROS) and a rheology modifier. Also presented...
2017/0216351 METHOD AND COMPOSITION FOR PREVENTION AND TREATMENT OF ORAL FUNGAL INFECTIONS
A composition of stabilized chlorine dioxide at a concentration range of about 0.0004% to about 0.8% (w/v) having anti fungal properties to prevent oral fungal...
2017/0216350 COMPOSITIONS OF ALUMINUM FLUORIDE AND METHODS OF USE THEREOF FOR THE TREATMENT AND PREVENTION OF ACTINIC...
The present invention is directed to methods and compositions for the treatment or prevention of actinic keratosis and/ or for countering the effects of skin...
2017/0216349 NON-AQUEOUS LIQUID AND SEMI-SOLID FORMULATIONS OF AMORPHOUS CALCIUM CARBONATE
The present invention provides stabilized amorphous calcium carbonate (ACC) formulations, comprising ACC and a non-aqueous liquid carrier in which the ACC is...
2017/0216348 METAL NANOCLUSTERS AND USES THEREOF
Provided herein are metal nanoclusters, having a high absorption to volume ratio, and uses of the same, such as in generating singlet oxygen, or in protecting...
2017/0216347 ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE, USE OF ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE AS...
The subject of the invention is an N-sulfonic polyallylamine derivative (NSPAH) with Formula 1, wherein R is --SO.sub.3.sup.- or --H, and n is an integer from...
2017/0216346 INJECTABLE COMPOSITIONS AND METHODS OF USE THEREOF
One aspect of the present invention relates generally to injectable compositions. In one embodiment, the compositions include 2-hydroxyethyl methacrylate and a...
2017/0216345 USE OF GASTROINTESTINALLY ADMINISTERED POROUS ENTERON SORBENT POLYMERS TO PREVENT OR TREAT RADIATION INDUCED...
Disclosed herein are compositions and methods for preventing or treating acute or chronic oral mucositis, esophagitis, enteritis, colitis, or gastrointestinal...
2017/0216344 PHARMACEUTICAL FORMULATIONS COMPRISING CHONDROITIN SULFATE AND HYALURONIC ACID DERIVATIVES
The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and...
2017/0216343 VISCOSUPPLEMENT COMPOSITION COMPRISING ULVAN FOR TREATING ARTHRITIS
There is described an ulvan containing composition. This composition is a viscosupplement composition and can be used in the treatment or prophylaxis of...
2017/0216342 DRUG FOR THE TREATMENT OF CHOLESTEROL ACCUMULATION DISORDERS, AND SCREENING METHOD FOR SAME
Provided is a pharmaceutical composition for the treatment of disorders such as Niemann-Pick disease and GM1 gangliosidosis which are caused by the storage of...
2017/0216341 COMPOSITION COMPRISING POLYGLUCOSAMINE-GLYOXYLATE SOLUTIONS MIXED WITH HYALURONAN
The present disclosure relates to a method which allows direct formation of gel-like solutions of polyglucosamine at neutral pH.apprxeq.7 to 8, eliminating the...
2017/0216340 A Nucleoside Derivative For Use As A Drug, Particularly For The Treatment Of Chronic Lymphocytic Leukemia
We disclose nucleoside derivatives useful as drugs, particularly for the treatment of chronic lymphocytic leukemia.
2017/0216339 ANTI-TUMOR AGENT CONTAINING ANTI-TUMOR PLATINUM COMPLEX, AND ANTI-TUMOR EFFECT ENHANCER
In order to provide a novel cancer treatment method using a FTD-TPI combination drug that exhibits markedly excellent anti-tumor effects with fewer side...
2017/0216338 CANCER CHEMOTHERAPY EMPLOYING HALOGENATED ANALOGS OF THYMIDINE
HAT-Pi chemotherapy arrests uncontrolled replication and metastatic migration of neoplastic cells by inhibiting enzymatic activity of poly (ADP-ribose)...
2017/0216337 COMPOSITIONS INCLUDING TRICIRIBINE AND EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR COMPOUNDS OR SALTS THEREOF...
This application relates to combination therapies including triciribine compounds and epidermal growth factor receptor inhibitor compounds, particularly...
2017/0216336 TOPICAL PHARMACEUTICAL FORMULATIONS CONTAINING A LOW CONCENTRATION OF BENZOYL PEROXIDE IN SUSPENSION IN WATER...
An aqueous formulation for topical application to the skin comprising water, a water-miscible organic solvent, and benzoyl peroxide, wherein the concentration...
2017/0216335 METHODS, COMPOSITIONS, AND FORMULATIONS FOR PREVENTING OR REDUCING ADVERSE EFFECTS IN A PATIENT
The present invention provides methods, compositions, formulations, and kits related to acadesine, or a prodrug, analog, or salt thereof, and/or a blood...
2017/0216334 Foamable Compositions, Breakable Foams And Their Uses
A substantially surface active agent-free foamable composition which includes short-chain alcohol, water, polymer, fatty alcohol or fatty acid or a combination...
2017/0216333 PAEONIFLORIN PREPARATIONS AND USES THEREOF FOR FAT REDUCTION
Disclosed are methods and preparations useful for reducing fat at a targeted area(s) on a human. The preparations comprise as an active ingredient an...
2017/0216332 SMALL MOLECULE ANTI-SCARRING AGENTS
Disclosed are methods of treating fibrosis in a patient in need thereof that includes administering to the patient an amount of an active agent, as identified...
2017/0216331 BETALAIN COMPOSITIONS AND METHODS THEREFOR
Contemplated compositions and methods employ betalains for treatment of various conditions, and especially osteoarthritis, sinusitis, contact dermatitis, acne,...
2017/0216330 USE OF RIBOSE FOR TREATMENT OF SUBJECTS HAVING CONGESTIVE HEART FAILURE
A method for treating a human subject having congestive heart failure is disclosed herein. An exemplary method includes orally administering a 10 g to 50 g...
2017/0216329 Ceramide-Rubusoside Nanomicelles and Their Use in Cancer Therapy
Water-soluble, cell-permeable nanomicelles containing ceramides and a steviol glycoside, such as rubusoside, are disclosed. The ceramide-steviol glycoside...
2017/0216328 METHODS AND COMPOSITIONS FOR MICROBIOME ALTERATION
A method to improve gastrointestinal health by colonic microbiome alteration, the method comprising administering to a subject in need thereof an effective...
2017/0216327 COMPOUNDS AND NAIL POLISH
Compositions, methods, and kits that deliver a compound, such as 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole, through a keratin substrate are presented.
2017/0216326 USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES
The present invention relates to a method for treating dermal inflammation and dermal diseases by local or systemic delivery, in a subject in need of such...
2017/0216325 (R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZ- YL)PYRROLIDIN-2-ONE AND ITS PRODRUGS...
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds...
2017/0216324 Osteoclast Inhibitors Such as Zoledronic Acid for Low Back Pain Treatment
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions,...
2017/0216323 Methods for Treating Viral Infections Using Hydrogen Sulfide Donors
Certain embodiments are directed to methods of treating respiratory infection by administering an H.sub.2S donor.
2017/0216321 LIQUID FORMULATIONS OF COMPOUNDS ACTIVE AT SULFONYLUREA RECEPTORS
The invention provides liquid formulations of compounds that act at sulfonylurea receptors that are suitable for intravenous and intra-arterial infusion....
2017/0216320 ASPIRIN FORMULATION FOR INCREASED EFFICACY
Provided are methods for enhancing the efficacy of aspirin. Also provided are methods for reducing pain or preventing or treating heart attack, stroke or blood...
2017/0216319 Treating Various Disorders Using TrkB Agonists
Novel compounds and methods for activating the TrkB receptor are provided. The methods include administering in vivo or in vitro a therapeutically effective...
2017/0216318 PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE DRUGS, CONTRACEPTIVE KITS COMPRISING ACTIVE DRUGS, AND METHODS OF...
A pharmaceutical composition comprising an active contraceptive drug and one or more pharmaceutically-acceptable excipients. The pharmaceutical composition,...
2017/0216317 COMBINATION THERAPIES AND METHODS OF USE THEREOF FOR TREATING CANCER
Pharmaceutical compositions including an effective amount of an antiandrogen or androgen antagonist in combination with a Plk inhibitor and methods of use...
2017/0216316 FARNESOID X RECEPTOR MODULATORS
The present invention provides a compound of formula (I): ##STR00001## or a pharmaceutically acceptable salt, solvate, or amino acid conjugate thereof, wherein...
2017/0216315 USES OF ERGOSTATRIEN-3beta-OL
A use of an active ingredient in the manufacture of a medicament or a preparation is provided, wherein the active ingredient is at least one of ...
2017/0216314 TOPICAL FORMULATIONS
The present disclosure is drawn to topical formulations and related methods. In one embodiment, a topical formulation is provided that includes an active...
2017/0216313 ORAL FORMULATION OF A-NOR-5a ANDROSTANE COMPOUND
An oral formulation, and preparation method and use thereof; the oral formulation comprises 1-50 parts by weight of an A-nor-5a-androstane compound, 20-95...
2017/0216312 STERODIAL COMPOSITIONS
Provided herein are steroid containing compositions suitable for providing therapeutically effective amounts of at least one steroid to individuals. Also...
2017/0216311 HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The...
2017/0216310 VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS
Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of...
2017/0216309 NANOSTRUCTURED FORMULATIONS FOR THE DELIVERY OF SILIBININ AND OTHER ACTIVE INGREDIENTS FOR TREATING OCULAR DISEASES
Formulations are described, containing silibinin or other active ingredients incorporated in lipid nanoparticle systems of the SLN and NLC type, and based on...
2017/0216308 POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT
The present invention relates in general to polymer-bioactive agent conjugates for delivering a bioactive agent to a subject. The polymer-bioactive agent...
2017/0216307 ADMINISTRATION OF AN ANTI-OBESITY COMPOUND TO INDIVIDUALS WITH RENAL IMPAIRMENT
The present disclosure relates to methods for weight management in an individual in need thereof by determining the level of renal sufficiency of the...
2017/0216306 A Use of Alkaloid in Preparing Pharmaceutical Compositions for Preventing or Treating Pulmonary Fibrosis
A new use of a compound as indicated in structural formula I in preparing medications for preventing and/or treating pulmonary fibrosis includes the compound...
2017/0216305 COMPOSITIONS COMPRISING MELOXICAM-CYCLODEXTRIN INCLUSION COMPLEXES AND METHODS OF TREATING ACUTE PAIN
The present invention is directed to a method of administering a meloxicam formulation to a mammalian subject in need thereof including: orally administering...
2017/0216304 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES
The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), to methods of preparing said...
2017/0216303 PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS
Phenoxy acetic acids and phenyl propionic acids and their use in treating type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, or...
2017/0216302 METHOD FOR TREATING CANCER BY COMBINED USE
It is intended to provide a medicament and a method for treating cancer comprising a compound having MDM2 inhibiting activity and a compound having FLT3...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.